Enabling immune infiltration of the tumor microenvironment
Glycyx is headquartered in San Francisco, United States.
Enabling immune infiltration of the tumor microenvironment
Glycyx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Glycyx — Funding & Investors." VCBacked, July 1, 2023, https://www.vcbacked.co/company/glycyx. Accessed October 4, 2026.
VCBacked. (2023). Glycyx — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/glycyx
{{cite web |title=Glycyx — Funding & Investors |url=https://www.vcbacked.co/company/glycyx |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated